Further to the announcement made by PureTech Health plc (“PureTech”) on 7 October 2022, Nektar announces that it has mutually agreed with PureTech to terminate discussions regarding a potential business combination.
Â
Citigroup Maintains Neutral on Norwegian Cruise Line, Raises Price Target to $24
Citigroup analyst James Hardiman maintains Norwegian Cruise Line (NYSE:NCLH) with a Neutral and raises the price target from $22 to $24.